Cumberland Pharmaceuticals (CPIX) Prepaid Assets (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Prepaid Assets of $2.1 million for Q1 2026, down 15.5% sequentially from $2.4 million in Q4 2025, and down 5.31% YoY from $2.2 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Prepaid Assets (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Prepaid Assets for 17 years, with the latest figure at $2.1 million in Q1 2026.
- Quarterly Prepaid Assets fell 5.31% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 5.31% YoY) and the FY2025 annual result came in at $2.4 million, down 12.25% from the prior year.
- Prepaid Assets eased to $2.1 million in Q1 2026 per CPIX's latest filing, from $2.4 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $3.7 million in Q3 2022 and troughed at $1.4 million in Q3 2025.
- A 5-year average of $2.5 million and a median of $2.4 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 196.95% in 2022, then slumped 47.28% in 2023.
- Over 5 years, Prepaid Assets stood at $3.1 million in 2022, then declined by 1.94% to $3.0 million in 2023, then retreated by 7.89% to $2.8 million in 2024, then declined by 12.25% to $2.4 million in 2025, then dropped by 15.5% to $2.1 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $2.1 million, $2.4 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 675,993.00 |
| Mar 31, 2026 | 2.07 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 2.79 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | 3.03 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 2.28 Mn |
| Mar 31, 2023 | 2.72 Mn |
| Dec 31, 2022 | 3.08 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Jun 30, 2022 | 2.84 Mn |
| Mar 31, 2022 | 3.56 Mn |
| Dec 31, 2021 | 3.34 Mn |
| Sep 30, 2021 | 1.26 Mn |